with insulin resistance; while no association was found using the DAD equation.
globally. As to June 2016, nearly 50% of them were accessing antiretroviral therapy (ART) . 1 Since the advent and widespread use of continuous antiretroviral therapy (ART), the life expectancy of people living with HIV has considerably increased, with a concomitant significant reduction in related mortality. Therefore, acquired immunodeficiency syndrome (AIDS)-defining illnesses have drastically declined in this specific population leading to the increase life quality gains and a consequential to the increase in the burden of aging noncommunicable diseases (NCDs) and their risk factors . 2 Thereby, the prevalence and burden of cardiovascular disease (CVD) and metabolic complications tend to grow within this population, occurring enven at a younger age than in the general population . 2, 3 In the last decade, despite the remarkable progress noted in the management of HIV infection worldwide, HIV/AIDS related deaths although in gradual decline, remain significant . 1 This is essentially the result of non-communicable co-morbidities led by cardiovascular and metabolic diseases . 3 NCDs kill more than 36 million people each year and 80% occur in low-and middle-income countries including most people in Africa. People infected with HIV present therefore a double burden of disease constituted from a close relationship between HIV, ART and CVDs.
Indeed, HIV and ART are recognized as independent factors associated with metabolic complications . 4, 5 The mechanism of the increased risk of CVDs among HIV-infected people is multifactorial and results from traditional risk factors and HIV and ART themselves . 6 Evidence suggest a higher prevalence of insulin resistance in HIV infected populations than in the general population ; 7 HIV infection increases by twice the risk for coronary heart disease . 6 The route of CVD pathophysiology in HIV-infected people is mainly supported by two well described metabolic disorders including dyslipidemia and insulin resistance resulting from the probable complex inter-action between the host's advancing age, the virus, the inflammatory process, and the ART . 8 To better tackle the increasing burden of CVDs in HIV-infected patients, all mechanisms resulting CVD in the occurrence among in this specific population should be clearly elucidated and subsequently attacked. However, studies investigating existence of any association between insulin resistance and cardiovascular risk factors in HIV-infected black Africans are scarce. Therefore, we designed the present study, which this study aimed to examine the following question: What is the relationship between insulin resistance and absolute CVD risk in a group of Black African people living with HIV? 
Methods

Ethical considerations
The study was approved by the Cameroon National Ethics Committee for Human Health
Research (Ethical approval N° 2015/12/710/CE/CNERSH/SP). All participants signed the informed consent form.
Study design and participants
This cross-sectional study was conducted from December 2015 to May 2016 at the HIV daycare unit of the Yaoundé Central Hospital. All apparently healthy patients aged 30 to 74 were included, unless they had a history of CVD, were pregnant or breastfeeding, or were on lipidlowering therapy or hormone therapy.
Data collection
Socio-demographic characteristics, history of HIV infection, and cardiovascular risk factors were collected. Family history of early CVD was defined as CVD in a first-degree male before the age of 55 or in a first-degree female relative before the age of 65 . 9 Smoking status was classified as never, former, or current. Hazardous alcohol drinking was defined by an AUDIT-C (Alcohol Use Disorders Identification Test-Consumption) score ≥ 4 for men and ≥ 3 for women . 10 Lack of physical activity was defined as absence of walking or any other intense physical activity at least once a week . 11 Participants stage of HIV infection was classified using the World Health Organization (WHO) clinical staging for HIV infection . 12 Body Mass Index (BMI) was classified as recommended by WHO . 13 Abdominal obesity was defined in accordance with the International Diabetes Federation (IDF) . 14 High blood pressure was defined as a systolic blood pressure (SBP) ≥ 140 mmHg and/or a diastolic blood pressure (DBP) ≥ 90 and/or self-reported history of antihypertensive medication . 15 Insulin was estimated with C-Peptide, which was measured using the sandwich immunoassay method (ELISA method). Dyslipidemia was considered as an elevated level of TC (> 6.2 mmol/L) and/or elevated level of LDL-C (> 4.1 mmol/L) and/or a low HDL-C level (< 1.04 mmol/L in men and 1.29 mmol/L in women) and/or a hypertriglyceridemia (≥ 1.7 mmol/L) . 16 We considered as having diabetes any patient with at least 2 FPG levels ≥ 7.0 mmol/L on two occasions at least 48 hours apart, or self-reported ongoing use of antidiabetic medications following a diagnosis made in a health facility . 17 Metabolic syndrome was defined using the International Diabetic Federation criteria . 
Results
Characteristics of the study population
Overall, we included 452 patients among whom 361 (79.9 %) were females. 
Relationship between CVD risk and insulin resistance
In univariable analysis, there was no significant association between the CVD risk (estimated Table 2 ). In multivariable analysis, the association between the CVD risk (assessed using the DAD equation) and the HOMA-IR index remained non-significant (β = 0.18; p = 0.429) ( Table 3) .
On the contrary, this association using the Framingham equation remained statistically significant (β = 0.64; p = 0.001) ( 
Discussion
The general objective of this study was to evaluate the relationship between CVD risk and insulin resistance among HIV-infected patients in Cameroon. As key findings, we found that the relationship between the CVD risk and insulin resistance varied depending on the risk equation used to assess this risk. Indeed, using the Framingham risk equation, participants with insulin resistance had a higher risk of CVD as compared to their counterparts without insulin resistance. Additionally, the relationship between the CVD risk and the HOMA-IR index was significant in univariable analysis as well as in multivariable linear regression analysis after adjusting for confounders. By contrast, all these associations were insignificant when the CVD risk was estimated with the DAD risk equation.
Calculated using the Framingham equation or the DAD equation, the median CVD risk was low in our study population. This can be explained by the relatively young age of participants and high proportion of females (80%). Indeed, the male sex is recognized as an independent risk factor for CVD. 21 Using both Framingham and DAD equations, we found that the proportion of subjects decreased progressively with increasing degree of cardiovascular risk ;
these results are probably due to the relative young age of the majority of our study population, are similar to those previously described in literature . 22, 23 In our study population, insulin resistance had a prevalence that was higher than that found by Guillen et al. in a population of 219 HIV-infected people in Peru (34.2%) while using the same HOMA-IR definition threshold. 6 Moreover, Guillen et al. reported a mean value of HOMA-IR index of 2.6 ± 3 less than that found in our study (3.85 ± 5.87). This difference may be due to the fact that the basal insulin secretion is high in African populations. 24 We found no significant relationship between insulin resistance and CVD risk calculated using the DAD equation. Indeed, there was no significant association between HOMA-IR index and the CVD risk calculated using this equation. Considering the CVD risk calculated by the Framingham equation, we found a significant association between HOMA-IR index and the insulin resistance in univariate analysis and after adjustment to other factors in multivariate analysis. This discrepancy may be related to the fact that the DAD and
Framingham risk score do not measure exactly the same. 22, 23 Therefore, longitudinal study need to be conduct in African populations to derive CVD risk assessment tool, for the general population, and for specific populations.
Unfortunately, we found no reason to explain this discrepancy. To the best of our knowledge, no previous study had investigated the relation between the risk of CVD and insulin resistance However, evidence accumulated from systematic reviews, cross-sectional and prospective cohort studies point in favor of an increased risk of developing a CVD among non-diabetes subjects presenting insulin resistance, despite some discrepancies between studies . 25, 26 Indeed, partly corroborating our findings, Schmiegelow et al. demonstrated a significant association in univariable analysis between the CVD risk estimated using the Framingham equation and insulin resistance assessed by the HOMA-IR index in a population of 15,288
postmenopausal US women; but this association became non-significant in multivariable analysis after adjusting for HDL-C . 27 Moreover, Howard et al. did not find a significant relationship between insulin resistance and atherosclerosis in African Americans, which on the contrary was significant among Euro-Americans .
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Our study presents some limitations. The sampling method was not random, perhaps hindering any generalization of our results. In the absence of locally-developed tools we used equations which were developed in Caucasian populations though the pattern of CVD may be different between Caucasians and Black Africans . 29 Finally, we used an indirect method to assess insulin resistance instead the hyperinsulinemic euglycemic clamp which is the gold standard . 30 Nevertheless, our sample size was large, and the study was the first to evaluate the direct relationship between CVD risk and insulin resistance as continuous variables in subSaharan Africans to the best of our knowledge. Also, we used rigorous methodological and statistical procedures to examine our research questions.
Conclusion
The relationship between insulin resistance and CVD risk may depend on the risk equation used. Further prospective cohort studies are warranted to better assess the relationship between CVD and insulin resistance in Black African HIV-infected patients. While waiting, preventing CVD in this population may call for implementation of programs aiming to reduce, delay or prevent insulin resistance occurrence.
Declarations Ethics approval and consent to participate
Research (Ethical approval N° 2015/12/710/CE/CNERSH/SP). All participants singed a consent form. with insulin resistance; while no linear association was found using the DAD equation.
Conclusion: The relationship between cardiovascular risk and insulin resistance in Black
African HIV infected patients seems to depend on the cardiovascular risk equation used.
Keywords: cardiovascular risk, HIV, insulin resistance, Cameroon.
Strengths and limitations of this study:
• To the best of our knowledge, this is the first study which assessed the direct relationship between cardiovascular risk and insulin resistance as continuous variables among HIV-infected people in sub-Saharan Africa.
• Rigorous methodological and statistical procedures were used to examine our research questions.
• This study aptly highlighted that the relationship between cardiovascular risk and insulin resistance in HIV-infected patients in sub-Saharan Africa depends on the cardiovascular risk equation used.
• The sampling method was not random, perhaps hindering the external validity of our results.
• An indirect method was used to assess insulin resistance instead the hyperinsulinemic euglycemic clamp which is the gold standard. For instance, HIV increases by twice the risk for coronary heart disease. 5 Moreover, HIV and ART are recognized as independent factors associated with metabolic complications . 6, 7 The mechanism of the increased risk of CVD among HIV-infected people is multifactorial, mainly supported by two well described metabolic disorders including dyslipidemia and insulin resistance, both of which result from the probable complex interaction between the host's advancing age, the virus, the inflammatory process, and the ART. 2 In this regard, evidence suggests a higher prevalence of insulin resistance in HIV-infected populations than in the general population. 8 To better tackle the increasing burden of CVDs in HIV-infected patients, all mechanisms implicated in CVD occurrence should be clearly elucidated and subsequently attacked.
However, studies investigating existence of any association between insulin resistance and cardiovascular risk factors in HIV-infected black Africans are scarce. Therefore, we designed the present study, which aimed to examine the following question: What is the relationship 
Methods
Ethical considerations
Study design and participants
Data collection
Socio-demographic characteristics, history of HIV infection, and cardiovascular risk factors were collected. Family history of early CVD was defined as CVD in a first-degree male before the age of 55 or in a first-degree female relative before the age of 65. 9 Smoking status was classified as never, former, or current. Hazardous alcohol drinking was defined by an AUDIT-C (Alcohol Use Disorders Identification Test-Consumption) score ≥ 4 for men and ≥ 3 for women . 10 Lack of physical activity was defined as absence of walking or any other intense physical activity at least once a week . 11 Participants stage of HIV infection was classified using the World Health Organization (WHO) clinical staging for HIV infection . 12 Body Mass Index (BMI) was classified as recommended by WHO . 13 Abdominal obesity was defined in accordance with the International Diabetes Federation (IDF) . 14 mmol/L in men and 1.29 mmol/L in women) and/or a hypertriglyceridemia (≥ 1.7 mmol/L) . 16 We considered as having diabetes any patient with at least 2 FPG levels ≥ 7.0 mmol/L on two occasions at least 48 hours apart, or self-reported ongoing use of antidiabetes medications 
Cardiovascular disease risk assessment
The 5-year risk of CVD was calculated using two equations; a non-specific equation (the Framingham-Anderson equation) 18 and a specific equation applied to people living with HIV (the DAD equation) .
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Insulin resistance evaluation
The HOMA-IR index served to assess the insulin sensitivity; it was determined by the formula: fasting blood glucose (mmol/L) x fasting Insulin (mU/L or µUl/mL) / 22.5 . 20 Insulin resistance was defined by any value of the HOMA-IR index equal or above 2.1; this threshold was defined in an HIV-infected population in Peru .
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Statistical analysis
Data were analyzed using the Statistical Package for Social Sciences (SPSS) software, version 
Results
Characteristics of the study population
Overall, we included 452 patients among whom 361 (79.9 %) were females. The mean age was 44.4 ± 9.8 years. Of the 452 participants, 400 (88.5%) were on continuous ART. The study population's characteristics are presented in table 1. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The median HOMA-IR index was 2.1 (1.4 -3.2) .
Relationship between CVD risk and insulin resistance
The CVD risk (estimated using the Framingham equation) of participants with insulin resistance was higher than that of participants without this condition: 4.1% (2.5-5.6) vs. 2.2%
(1.7-3.7); p < 0.001. But using the DAD equation, there was no difference between CVD risk of participants with insulin resistance and those without: 1.9% (1.4-2.9) vs. 1.5% (1.1-2. Table 2 ). The regression equation of these associations are presented below. In multivariable analysis, the association between the CVD risk (assessed using the DAD equation) and the HOMA-IR index remained non-significant (β = 0.18; p = 0.429) ( Table 3) .
On the contrary, this association using the Framingham equation remained statistically significant (β = 0.64; p = 0.001) ( Table 3) . 
Discussion
The general objective of this study was to evaluate the relationship between CVD risk and insulin resistance among HIV-infected patients in Cameroon. As key findings, we observed that the relationship between the CVD risk and insulin resistance varied depending on the risk equation used. Indeed, using the Framingham risk equation, participants with insulin resistance had a higher risk of CVD as compared to their counterparts without insulin resistance. Additionally, the relationship between the CVD risk and the HOMA-IR index was significant in univariable analysis as well as in multivariable linear regression analysis after adjusting for confounders. By contrast, all these linear associations were insignificant when the CVD risk was estimated with the DAD risk equation.
Calculated using the Framingham equation or the DAD equation, the median CVD risk was lower in our study population. This can be explained by the relatively young age of our participants and the high proportion of females (80%). Indeed, the male sex is recognized as an independent risk factor for CVD. 22 Using either Framingham or the DAD equations, we found that the proportion of subjects decreased progressively with increasing degree of cardiovascular risk. These results are similar to those already reported. 23, 24 and are probably due to the relative young age of the majority of our study population.
In this study, insulin resistance had a higher prevalence than that found by Guillen et al. in a population of 219 HIV-infected people in Peru (34.2%) while using the same HOMA-IR definition threshold. 5 Moreover, Guillen et al. reported a mean value of HOMA-IR index of 2.6 ± 3 less than that found in our study (3.85 ± 5.87 ). This difference may be due to the fact that the basal insulin secretion is high in African populations. 25 We found no significant relationship between insulin resistance and CVD risk calculated Our study presents some limitations. The sampling method was not random, perhaps hindering any generalization of our results. In the absence of locally-developed tools we used equations which were developed in Caucasian populations though the pattern of CVD may be different between Caucasians and Black Africans . 30 The cut-off used to define insulin resistance in our study was first used in a Peruvian HIV-infected population.
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, this may have perhaps overestimated the prevalence of insulin resistance in our study given that basal insulin secretion may be higher in Africans 25 . However, the results of the association between the CVD risk and categorical insulin resistance (based on HOMA-IR index cut-off) were confirmed by to the results of the linear association between the CVD risk and HOMA-IR.
Finally, we used an indirect method to assess insulin resistance instead of the hyperinsulinemic euglycemic clamp which is the gold standard. 31 Nevertheless and to the best Furthermore, our sample size was large and we used rigorous methodological and statistical procedures to examine our research questions.
Conclusion
The relationship between insulin resistance and CVD risk may depend on the risk equation used. Further prospective cohort studies are warranted to better assess the relationship between CVD and insulin resistance in Black African HIV-infected patients. While waiting, preventing CVD in this population may call for implementation of programs aiming to reduce, delay or prevent the occurrence of insulin resistance.
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